Curology is a prominent player in the Consumer Goods, Health Care, and Wellness Beauty sectors, dedicated to the mission of making effective skincare accessible. Founded in 2014 and headquartered in the United States, the company specializes in personalized prescription medications tailored to individual skin needs, providing a unique customer experience through direct delivery and 1:1 consultations with dermatology providers.
Curology's expertise in both acne and anti-aging solutions positions it as a transformative force in accessible skincare. Their offerings include a diverse range of dermatologist-designed cosmetic and OTC products, enhancing their holistic service model. The company last received a late-stage VC investment on April 1, 2021, with backing from investors including Anthos Capital, ACME Capital, and AVP | Advance Venture Partners. This backing underscores investor confidence in Curology's innovative approach and market potential.